Risk of Short-Term Stroke in Non-High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis
- 1Department of Cardiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330031 Nanchang, Jiangxi, China
- 2Jiangxi Hypertension Research Institute, 330006 Nanchang, Jiangxi, China
- 3Jiangxi Medical College, Nanchang University, 330031 Nanchang, Jiangxi, China
Abstract
Background:: To compare the incidence of stroke at 1 and 2 years following transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR), aiming to inform clinical decision-making regarding the safety and effectiveness of these interventions.
Methods:: A random-effects meta-analysis was conducted including 9 randomized controlled trials (RCTs) with a total of 9865 patients. The primary endpoint was the incidence of stroke at 1 and 2 years post-procedure.
Results:: At 1 year, TAVR was associated with a lower incidence of stroke compared with SAVR (odds ratio (OR), 0.77; 95% confidence interval (CI), 0.61–0.98; p = 0.03). No significant difference was observed at 2 years (OR, 0.87; 95% CI, 0.65–1.17; p = 0.37).
Conclusions:: TAVR significantly reduces the risk of stroke within 1 year post-procedure compared with SAVR; however, this effect was not maintained at 2 years. These findings highlight the early benefit of TAVR, while the long-term advantage requires further investigation.
The PROSPERO Registration:: This study has been registered with PROSPERO, registration number: CRD42025636191, https://www.crd.york.ac.uk/PROSPERO/view/CRD42025636191.
Related
- Clinical Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Pure Native Aortic Regurgitation: A Systematic Review and Meta-Analysis
- Outcomes of Surgical Versus Transcatheter Mitral Valve Repair or Replacement in Patients With Myocardial Infarction and Concomitant Mitral Regurgitation: A Retrospective Analysis of Real-World Data
- Outcomes of rescue procedures in patients undergoing unsuccessful deployment of transcatheter mitral valve replacement.
- Prognostic Value of the Frailty Index in Patients with Severe Aortic Regurgitation Undergoing Transcatheter Aortic Valve Replacement.
- Coronary artery disease management in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis of randomised controlled trials
BibTeX
@article{liu2026risk,
title = {{Risk of Short-Term Stroke in Non-High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis}},
author = {Haochen Liu and Zhidan Xiao and Jiahao Zou and Xiaoping Peng},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
month = sep,
doi = {10.31083/rcm49672},
url = {https://doi.org/10.31083/rcm49672},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Risk of Short-Term Stroke in Non-High-Risk Patients Undergoing Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis
AU - Haochen Liu
AU - Zhidan Xiao
AU - Jiahao Zou
AU - Xiaoping Peng
PY - 2026
DA - 2026/09/30
JO - Reviews in Cardiovascular Medicine
DO - 10.31083/rcm49672
UR - https://doi.org/10.31083/rcm49672
AB - Background:: To compare the incidence of stroke at 1 and 2 years following transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR), aiming to inform clinical decision-making regarding the safety and effectiveness of these interventions. Methods:: A random-effects meta-analysis was conducted including 9 randomized controlled trials (RCTs) with a total of 9865 patients. The primary endpoint was the incidence of stroke at 1 and 2 years post-procedure. Results:: At 1 year, TAVR was associated with a lower incidence of stroke compared with SAVR (odds ratio (OR), 0.77; 95% confidence interval (CI), 0.61–0.98; p = 0.03). No significant difference was observed at 2 years (OR, 0.87; 95% CI, 0.65–1.17; p = 0.37). Conclusions:: TAVR significantly reduces the risk of stroke within 1 year post-procedure compared with SAVR; however, this effect was not maintained at 2 years. These findings highlight the early benefit of TAVR, while the long-term advantage requires further investigation. The PROSPERO Registration:: This study has been registered with PROSPERO, registration number: CRD42025636191, https://www.crd.york.ac.uk/PROSPERO/view/CRD42025636191.
SN - 1530-6550
SN - 2153-8174
ER -